Noveris Health Sciences Inc (MYCOF) Stock Price & News

All values in CAD	2025-ж. сен.	2025-ж. дек.	2026-ж. мар.	2026-ж. июн.
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-40,14 миң	-	-	32,79 миң
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	-70,57 миң	5,04 миң	316,29 миң	669,62 миң
Operating expense	-110,70 миң	5,04 миң	316,29 миң	702,42 миң
Total operating expenses	-110,70 миң	5,04 миң	316,29 миң	702,42 миң
Operating income	110,70 миң	-5,04 миң	-316,29 миң	-702,42 миң
Other non operating income	85,53 миң	-417,63 миң	-1,32 млн	640,56 миң
EBT including unusual items	73,79 миң	3,16 млн	-1,62 млн	22,81 миң
EBT excluding unusual items	73,79 миң	-405,27 миң	-1,62 млн	-155,29 миң
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	73,79 миң	3,16 млн	-1,62 млн	22,81 миң
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	-	-	-	-
Interest expense	-	-26,16 миң	-12,63 миң	-9,90 миң
Net interest expenses	-	-26,16 миң	-12,63 миң	-9,90 миң
Depreciation and amortization charges	-	-	-	-
EBITDA	-	-	-	-
Gain or loss from assets sale	-	-	-	-

Finance